Home > Boards > US Listed > Biotechs > Chembio Diagnostics (CEMI)

hop in now, Only a 100 million market

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ATCrunch Member Profile
 
Followed By 25
Posts 855
Boards Moderated 0
Alias Born 05/25/14
160x600 placeholder
Chembio Diagnostics to Report Third Quarter 2020 Financial Results on November 5, 2020 GlobeNewswire Inc. - 10/23/2020 8:00:10 AM
Chembio Diagnostics Submits EUA Application for DPP SARS-CoV-2 Antigen Test System GlobeNewswire Inc. - 10/15/2020 5:55:10 PM
Chembio Diagnostics Receives FDA Approval for DPP HIV-Syphilis System GlobeNewswire Inc. - 10/2/2020 7:26:09 AM
Chembio Submits EUA Application for New DPP SARS-CoV-2 IgM/IgG Test System GlobeNewswire Inc. - 9/8/2020 6:01:08 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2020 7:43:29 AM
Chembio Diagnostics Reports Second Quarter 2020 Financial Results GlobeNewswire Inc. - 8/6/2020 4:05:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2020 7:19:40 AM
Chembio Diagnostics to Report Second Quarter 2020 Financial Results on August 6, 2020 GlobeNewswire Inc. - 7/23/2020 4:10:10 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/8/2020 10:00:37 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/8/2020 9:43:40 AM
Chembio Diagnostics Announces Preliminary Estimates of Second Quarter 2020 Revenues GlobeNewswire Inc. - 7/6/2020 4:23:03 PM
Chembio Announces Plans to Seek EUA Approval from FDA for Revised DPP COVID-19 IgM/IgG System and New DPP COVID-19 Antigen Sy... GlobeNewswire Inc. - 7/6/2020 4:11:10 PM
Chembio Diagnostics Awarded BARDA Contract for Development of DPP COVID-19 Point-of-Care Antigen System GlobeNewswire Inc. - 7/6/2020 4:10:10 PM
Chembio to Report COVID-19 Product Development Plans and Preliminary Estimated Second Quarter 2020 Revenue Results GlobeNewswire Inc. - 7/1/2020 5:00:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/17/2020 6:50:53 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 6/16/2020 5:22:00 PM
Chembio Diagnostics Receives FDA 510(k) Clearance for DPP Zika IgM System GlobeNewswire Inc. - 6/8/2020 8:00:10 AM
Chembio Diagnostics Strengthens Commercial Organization GlobeNewswire Inc. - 6/2/2020 8:00:10 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 5/29/2020 5:30:08 PM
Chembio Diagnostics to Participate in Upcoming Investor Conferences GlobeNewswire Inc. - 5/26/2020 4:15:10 PM
Chembio Diagnostics Announces US Distribution Agreement to Expand Reach of DPP COVID-19 Serological Test with Thermo Fisher S... GlobeNewswire Inc. - 5/18/2020 7:00:10 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 5/11/2020 4:45:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/11/2020 4:38:29 PM
Chembio Diagnostics Announces Closing of Public Offering of Common Stock GlobeNewswire Inc. - 5/11/2020 10:20:50 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/8/2020 6:10:30 AM
ATCrunch   Wednesday, 04/01/20 10:01:12 AM
Re: None
Post # of 448 
hop in now, Only a 100 million market cap. Could hit 300 if we get some order numbers or good news

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences